"Payviders" are responsible for the cost of avoidable readmissions and emergency room visits, but they lose sight of patients once they go home.
|Videos|October 14, 2021
- MHE October 2021
- Volume 31
- Issue 10
Manik Bhat Discusses "Managing Mission and Growth" and the Sacrifices Made by His Parents
Author(s)Peter Wehrwein
In this video segment, Bhat discusses his early career as community health worker in East Baltimore and starting and leading the growth of Healthify, a company that helps healthcare organizes address the social determinants of health. Healthify has recently been acquired by Wellsky and Bhat's title is vice president of SDOH operations and sales. Bhat also discusses the sacrifices his parents made for him and his brother and their work ethic.
Advertisement
Articles in this issue
about 5 years ago
Emerging Health Leaders: Sonia Samagh of Stealth Ventureabout 5 years ago
Emerging Health Leaders: Andrew Toy, M.S., of Clover Healthabout 5 years ago
Emerging Health Leaders: Evie Powell, Ph.D., of Proprioabout 5 years ago
Emerging Health Leaders: Michael Palantoni of AthenahealthAdvertisement
Related to this article
Jenny Goins, interim head of the National Alliance of Healthcare Purchaser Coalitions, says employers need the same visibility into medical benefits that a new Department of Labor rule gives them into PBM compensation.
Only 19% of community oncologists use AI predictive models. Prerna Mewawalla, M.D., outlines six ways AI can already help in myeloma care.
Jamilia Sherls, DNP, says health systems should track vaccine coverage closely and look to AAP schedules if federal guidance isn't evidence-based.
Model N's Jesse Mendelsohn explains why drug manufacturers argued that a 340B rebates instead of upfront discounts will avoid an overlapping maximum fair price and 340B discounts
People with ADHD had a 70% higher risk of death from any cause in a 19-study meta-analysis, with excess deaths from suicide, injury and natural causes.
Bronchiectasis affected 221.6 per 100,000 people in the U.S. over five years, which is higher than earlier national estimates, according to a study published in CHEST.
Cepheid’s Xpert Respiratory Panel, which tests one swab for nine viruses and four bacteria, is now certified for sale in Europe under the IVDR.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Six jobs for AI in myeloma care, from Prerna Mewawalla, M.D.
2
Vaccine schedule overhaul could put coverage at risk, state official says
3
The payvider blind spot: When clinical visibility ends but financial risk continues
4
Bronchiectasis is more common in the U.S. than a decade ago, study finds
5